| 000 | 01093nam a2200289 i 4500 | ||
|---|---|---|---|
| 001 | 91198 | ||
| 003 | MX-SnUAN | ||
| 005 | 20160901122358.0 | ||
| 008 | 120403 g 00 spa d | ||
| 020 | _a1573312010 | ||
| 035 | _avtls000059365 | ||
| 039 | 9 |
_a201406141210 _bVLOAD _c201406061355 _dVLOAD _c201303162237 _dVLOAD _c201204031504 _dVLOAD _y201105171854 _zVLOAD |
|
| 040 |
_aMX-SnUAN _bspa _cMX-SnUAN _erda |
||
| 050 | 1 | 4 |
_aRL97 _bC8 1999 |
| 245 | 0 | 0 |
_aCutaneous neuroimmunomodulation : _bthe proopiomelanocortin system / _ced. Thomas A. Luger... [et al] |
| 264 | 1 |
_aNew York : _bThe New York Academy of Sciences, _c1999. |
|
| 300 | _axiv, 479 páginas | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_ano mediado _bn _2rdamedia |
||
| 338 |
_avolumen _bnc _2rdacarrier |
||
| 490 | 0 | _aAnnals of the New York Academy of Sciences ; | |
| 500 | _aEjemplar de FG ubicado fisicamente en FHI | ||
| 650 | 4 |
_aPiel _xEnfermedades _958513 |
|
| 700 | 1 |
_aLuger, Thomas A. _987133 |
|
| 942 | _c1 | ||
| 999 |
_c91198 _d91198 |
||
| 999 | _aVTLSSORT0010*0080*0200*0350*0400*0500*2450*2600*3000*4900*5000*6500*7000*8300*9490*9993 | ||